Workstream Type: Data Analysis
-
Cardiovascular Drugs Not Price Aligned with Value in US
Read More
-
Spending On Prescription Drugs In The US: Where Does All The Money Go?
Read More
-
Impact of President Trump’s Proposed 340B Hospital Eligibility Threshold
Read More
-
Does the 6% in Medicare Part B Drug Reimbursement Affect Prescribing?
Read More
-
Association of Rebates in Part D with Patient OOP and Federal Spending
Read More
-
R&D Costs Do Not Explain Elevated U.S. Drug Prices
Read More
-
Hospital Outpatient versus Doctor Office Cost for Physician Administered Cancer Drugs
Read More
-
Part B Pilot Congressional Concerns
Read More
-
Part B Payment for Medicare Drugs
Read More
-
Overspending Driven by Oversized Single Dose Vials of Cancer Drugs
Read More